CPRX icon

Catalyst Pharmaceutical
CPRX

Overview Fund Activity

313 hedge funds and large institutions have $1.89B invested in Catalyst Pharmaceutical in 2024 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 97 increasing their positions, 105 reducing their positions, and 22 closing their positions.

Holders
313
Holders Change
+42
Holders Change %
+15.5%
% of All Funds
4.53%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
65
Increased
97
Reduced
105
Closed
22
Calls
$610K
Puts
$1.58M
Net Calls
-$970K
Net Calls Change
-$703K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$36.2M
2
Qube Research & Technologies (QRT)
2
Qube Research & Technologies (QRT)
United Kingdom
$13.3M
3
Millennium Management
3
Millennium Management
New York
$11.1M
4
Skandinaviska Enskilda Banken (SEB)
4
Skandinaviska Enskilda Banken (SEB)
Sweden
$8.35M
5
Goldman Sachs
5
Goldman Sachs
New York
$29.3M

Top Sellers

1
DM
1
Deerfield Management
New York
$124M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$7.16M
3
Citadel Advisors
3
Citadel Advisors
Florida
$502K
4
OM
4
Opaleye Management
Massachusetts
$2.24M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$378M 19,017,491 +322,573 +2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$160M 8,040,978 -59,377 -0.7%
DM
3
Deerfield Management
New York
$124M 6,229,634 -2,897,671 -32%
State Street
4
State Street
Massachusetts
$113M 5,685,330 -347,968 -6%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$60M 3,018,789 +18,033 +0.6%
Pacer Advisors
6
Pacer Advisors
Pennsylvania
$55.7M 2,804,013 -163,562 -6%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$53M 2,664,424 -34,189 -1%
Renaissance Technologies
8
Renaissance Technologies
New York
$50.2M 2,526,016 +350,289 +16%
First Trust Advisors
9
First Trust Advisors
Illinois
$48.3M 2,428,973 -43,960 -2%
RA
10
Royce & Associates
New York
$40.2M 2,021,105 -140,917 -7%
Morgan Stanley
11
Morgan Stanley
New York
$36.2M 1,823,274 +810,595 +80%
Goldman Sachs
12
Goldman Sachs
New York
$29.3M 1,472,253 +384,122 +35%
Northern Trust
13
Northern Trust
Illinois
$27.5M 1,383,800 -2,907 -0.2%
Boston Partners
14
Boston Partners
Massachusetts
$25.6M 1,275,267 -131,113 -9%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$24.5M 1,234,383 +1,531 +0.1%
Charles Schwab
16
Charles Schwab
California
$23.2M 1,167,743 +50,804 +5%
Nuveen Asset Management
17
Nuveen Asset Management
Illinois
$22.6M 1,139,142 +308,586 +37%
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$21M 1,057,390 -284,174 -21%
KCM
19
Kennedy Capital Management
Missouri
$20.7M 1,041,416 -234,888 -18%
LSV Asset Management
20
LSV Asset Management
Illinois
$18.9M 951,324 +77,424 +9%
Invesco
21
Invesco
Georgia
$18.7M 939,526 +100,071 +12%
Marshall Wace
22
Marshall Wace
United Kingdom
$17.1M 860,934 -358,603 -29%
MIIM
23
Mesirow Institutional Investment Management
Illinois
$15.9M 800,798 -133,436 -14%
Voloridge Investment Management
24
Voloridge Investment Management
Florida
$15.3M 767,229 +12,504 +2%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$14.2M 714,351 -120,064 -14%
1
2 3 4 5